Skip to content

Hepatoprotective effects of a semaglutide, elafibranor and resmetirom in the non-obese CDAA-HFD rat model of advanced MASH with progressive fibrosis

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 ­2650

Back To Top